Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial

[1]  A. Seguro,et al.  Renal tubular dysfunction in patients with American cutaneous leishmaniasis. , 2011, Kidney international.

[2]  N. Rocha,et al.  Renal Function Improvement with Pentavalent Antimonial Agents in Patients with Visceral Leishmaniasis , 2011, American Journal of Nephrology.

[3]  E. Khalil,et al.  Surrogate markers of subtle renal injury in patients with visceral leishmaniasis. , 2010, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[4]  S. Mehta.  Developing the right pneumococcal vaccine for the time and place. , 2010, The American journal of tropical medicine and hygiene.

[5]  H. Goto,et al.  Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis , 2010, Expert review of anti-infective therapy.

[6]  N. Rocha,et al.  Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar). , 2010, The American journal of tropical medicine and hygiene.

[7]  S. Haider,et al.  Systemic therapy of New World cutaneous leishmaniasis: A case report and review article. , 2010, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[8]  A. Martins,et al.  Evaluation of renal function in leprosy: a study of 59 consecutive patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  G. S. Silva Júnior,et al.  Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. , 2007, Journal of nephrology.

[10]  Felipe Freitas da Rocha,et al.  Leishmaniose tegumentar americana , 2006 .

[11]  P. Desjeux.  Leishmaniasis: current situation and new perspectives. , 2004, Comparative immunology, microbiology and infectious diseases.

[12]  D. Fouque,et al.  [A patient with visceral leishmaniasis and acute renal failure in necrotizing glomerulonephritis]. , 2004, Nephrologie.

[13]  J. M. L. Costa,et al.  Envolvimento da função renal em pacientes com leishmaniose visceral (calazar) , 2003 .

[14]  S. Foote,et al.  Science, medicine, and the future: Leishmaniasis , 2000, BMJ : British Medical Journal.

[15]  T. Debord,et al.  Néphropathies parasitaires importées : mise au point à partir de la littérature récente , 1999 .

[16]  T. Debord,et al.  [Important parasitic nephropathies: update from the recent literature]. , 1999, Nephrologie.

[17]  N. Foss,et al.  Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous leishmaniasis. , 1999, Revista do Instituto de Medicina Tropical de Sao Paulo.

[18]  C. D. D. de Paula,et al.  [The evaluation of the tolerance and nephrotoxicity of pentavalent antimony administered in a dose of 40 mg Sb V/kg/day, 12/12 hr, for 30 days in the mucocutaneous form of leishmaniasis]. , 1997, Revista da Sociedade Brasileira de Medicina Tropical.

[19]  G. Kirsztajn,et al.  Renal abnormalities in leprosy. , 1993, Nephron.

[20]  R. Badaró,et al.  Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. , 1991, The American journal of tropical medicine and hygiene.

[21]  G. Grimaldi,et al.  Leishmaniasis and its etiologic agents in the New World: an overview. , 1991, Progress in clinical parasitology.

[22]  W. B. Junior,et al.  Nephrotoxicity to Glucantime® in the treatment of Leishmaniasis , 1990 .

[23]  L. C. Cucé,et al.  Alterações renais por hipersensibilidade ao uso de antimonial pentavalente (Glucantime®) na leishmaniose tegumentar americana: relato de um caso , 1990 .

[24]  H. Friedman,et al.  Pentavalent antimonial nephrotoxicity in the rat. , 1990, Revista do Instituto de Medicina Tropical de Sao Paulo.

[25]  Donna,et al.  Acute interstitial nephritis , 1980 .

[26]  E. Carvalho,et al.  Renal involvement in visceral leishmaniasis. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  H. Goto,et al.  Interstitial nephritis in human kala-azar. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.